primary%20open-angle%20glaucoma
PRIMARY OPEN-ANGLE GLAUCOMA
Primary open-angle glaucoma (POAG) is a chronic, progressive, usually bilateral disease of the eye with an insidious onset.
It is most often characterized by optic nerve damage, defects in the retinal fiber layer and subsequent visual field loss in the absence of underlying ocular disease or congenital abnormalities.
It is generally asymptomatic until it has caused a significant loss of visual field.
Occasionally, patients with very high intraocular pressure may complain of nonspecific headache, discomfort, intermittent blurring of vision or even halos caused by corneal edema.
Drug Information

Indication: Decreased IOP in adult patients w/ open-angle glaucoma or ocular HTN for whom monotherapy provides insufficien...

Indication: Elevated IOP in ocular HTN or open-angle glaucoma.

Indication: Chronic open-angle glaucoma, ocular HTN.

Indication: Elevated IOP in patients w/ ocular HTN & open-angle glaucoma when concomitant therapy is appropriate.

Indication: Decrease of IOP in adults w/ open-angle glaucoma or ocular HTN who are insufficiently responsive to topical &b...

Indication: Elevated IOP in patients w/ ocular HTN or open-angle glaucoma.

Indication: Decrease of elevated IOP in adults w/ ocular HTN or open-angle glaucoma.

Indication: Reduction of elevated IOP in patients w/ open-angle glaucoma, chronic angle closure glaucoma & ocular HTN;...

Indication: Reduction of IOP in patients w/ primary open-angle glaucoma or ocular HTN.

Indication: Reduction of IOP in patients w/ primary open-angle glaucoma or ocular HTN.

1  /  3
Editor's Recommendations
Most Read Articles
Tristan Manalac, 25 Jan 2020
Unusual involvement of the eyes with atypical presentations may occur in patients with inflammatory bowel diseases (IBD) on antitumour necrosis factor (anti-TNF) therapy, according to a recent study presented at the 2019 Advances in Inflammatory Bowel Diseases Annual Meeting (AIBD 2019).